Tomomi Hamaguchi
Yokohama, 2360004, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Programmed death-ligand 1 expression in gastric cancer by the combined positive score using the PD-L1 IHC 28-8 pharmDx test: a single institution's experience.
Journal: Japanese journal of clinical oncology
Published: March 31, 2026
Feasibility of Peroral Pancreatoscopy Using the 9-Fr eyeMAX for Surgical Planning in Main-Duct and Mixed-Type Intraductal Papillary Mucinous Neoplasms.
Journal: Diagnostics (Basel, Switzerland)
Published: March 30, 2026
Proton Pump Inhibitor-Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy.
Journal: DEN open
Published: December 01, 2025
Feasibility of Endoscopic Closure Method Using Low Cost Clips With Thread for Post Gastric Endoscopic Submucosal Dissection: A Pilot Study.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: November 12, 2025
Endoscopic transpapillary gallbladder drainage for localized acute cholecystitis confined by segmental adenomyomatosis using a novel rotatable sphincterotome.
Journal: Endoscopy
Published: November 05, 2025
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer.
Journal: Therapeutic advances in medical oncology
Published: February 03, 2025
Comparison of carbon ion radiotherapy and transarterial chemoembolization for unresectable solitary hepatocellular carcinoma >3 cm: a propensity score-matched analysis.
Journal: Journal of radiation research
Published: October 28, 2024
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case Report.
Journal: Case reports in gastroenterology
Published: February 28, 2024
Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil.
Journal: Journal of personalized medicine
Published: April 11, 2023
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
Journal: Anticancer research
Published: March 19, 2023
Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/Tipiracil.
Journal: Anticancer research
Published: January 16, 2023
Last Updated: 09/26/2026